The FDA has expanded the approval of an intravenous injection for the treatment of metastatic or unresectable melanoma to include use in pediatric patients.
The FDA has expanded the approval of an intravenous injection for the treatment of metastatic or unresectable melanoma to include use in pediatric patients.
After clinical trials demonstrated its efficacy and safety, the FDA has approved a new treatment option for patients with chronic hepatitis C virus without cirrhosis or with mild cirrhosis.
After clinical trials demonstrated its efficacy and safety, the FDA has approved a new treatment option for patients with chronic hepatitis C virus without cirrhosis or with mild cirrhosis.
After clinical trials demonstrated its efficacy and safety, the FDA has approved a new treatment option for patients with chronic hepatitis C virus without cirrhosis or with mild cirrhosis.
The US Food and Drug Administration recently approved a new treatment option for patients with early stage HER2-overexpressed/amplified breast cancer. For recommended dosage and common adverse events, read...
The US Food and Drug Administration recently approved a new treatment option for patients with early stage HER2-overexpressed/amplified breast cancer. For recommended dosage and common adverse events, read...
